A Chinese company providing production and technical service of human vaccines looks for European agents and distributors for partnership through commercial agreement

A Chinese company has long been engaged in R&D, production, sales and technical services of preventive biological products. The current product line includes Group ACYW135 Meningococcal Polysaccharide Vaccine, Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cell)-HDCV, etc. It is now seeking for European agents and distributors for partnership that could be carried out via a commercial agency or distribution agreements.

The Chinese company was founded in 2004. It is one of the thirteen enterprises with whole vaccine production capacity in China. Its modern R&D and production base covers an area of 30,000sqm, and is equipped with advanced hardware and facilities, including a bio-technology center, a Specific Pathogen Free (SPF) laboratory, workshops for bacterial and viral vaccines. It has long been engaged in R&D, production, sales and technical services of preventive biological products. Its current products include Group ACYW135 Meningococcal Polysaccharide Vaccine, Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cell)-HDCV, etc. The sales channel of both products has been expanded across China. Group ACYW135 Meningococcal Polysaccharide Vaccine has been on overseas markets too. The company has passed the national Good Manufacturing Practices (GMP) inspection. In recent years, it has undertaken several technical research projects and successfully applied for hundreds of technique patents. The company dedicates itself to producing world-class human vaccines and is continuously improving the manufacturing techniques and processes. With the company's business strategy, it is aspiring to promote its products to more countries, especially those in Europe. It seeks for partnership with European agents and distributors with sound sales channel and adequate experience in healthcare sector, preferably vaccine sphere. Desired cooperation could be worked out under a commercial agency or distribution agreement.